Abstract:
To study the indicators of humoral immunity in patients with type 2 diabetes mellitus (DM) with dia betic nephropathy. Identification of epidemiological and pathophysiological relationships between diabetes mellitus
and COVID-19, assessment of prognosis to ensure better treatment results for this category of patients